Prevention of Torsade de Pointes in Hospital Settings: A Scientific Statement From the American Heart Association and the American College of Cardiology Foundation

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome

Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,053

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975

Drug-induced prolongation of the QT interval

Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome

Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682

Risk Stratification in the Long-QT Syndrome

Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,456

MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia

Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353

Approaches to Sudden Death from Coronary Heart Disease

Lown, B., & Wolf, M. A. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,258

Atypical antipsychotic drugs and the risk of sudden cardiac death

Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194

Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P.-E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012

Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs

Makkar, R. (1993) · JAMA · doi:10.1001/jama.270.21.2590 · Cited by 972

The long QT syndrome. Prospective longitudinal study of 328 families.

Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J. W., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 966

Untitled work

Kligfield (2007) · doi:10.1161/circulationaha.106.180200 · Cited by 802

Influence of the Genotype on the Clinical Course of the Long-QT Syndrome

Zaręba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 749

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Antzelevitch, C. N., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Diego, J. M. D., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 674

Terfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences

Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664

Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes

Roden, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 662

Mechanism of the Cardiotoxic Actions of Terfenadine

Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646

Practice Standards for Electrocardiographic Monitoring in Hospital Settings: An American Heart Association Scientific Statement From the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses

Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C., Swiryn, S., & Van Hare, G. F. (2004) · Circulation · doi:10.1161/01.cir.0000145144.56673.59 · Cited by 609

Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes

Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M. S., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 551

Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia

Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 526

Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care

Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 489

Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patients

Kay, G. N., Plumb, V. J., Arciniegas Joaquin, G., Henthorn, R. W., & L, W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P. G., Verheugt, F. W. A., Gersh, B. J., McCabe, C. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.724880 · Cited by 444

Extracellular Potassium Modulation of Drug Block of IKr

Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 430

Torsade de Pointes Associated with Very-High-Dose Methadone

Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00010 · Cited by 424

Long QT Syndrome in Adults

Sauer, A. J., Moss, A. J., McNitt, S. A., Peterson, D. R., Zaręba, W., Robinson, J. L., Qi, M., Goldenberg, I., Hobbs, J. B., Ackerman, M. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.057 · Cited by 417

[Ventricular tachycardia with 2 variable opposing foci].

Dessertenne, F. (1966) · PubMed · Cited by 414

Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one

Viskin, S., Rosovski, U., Sands, A. J., Chen, E., Kistler, P. M., Kalman, J. M., Chávez, L. R., Torres, P. I., Cruz, F. E. S., Centurión, O. A., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.02.011 · Cited by 406

Rate-corrected QT interval: Techniques and limitations

Funck‐Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401

Increased Short-Term Variability of Repolarization Predicts d -Sotalol–Induced Torsades de Pointes in Dogs

Thomsen, M. B., Verduyn, S. C., Štengl, M., Beekman, J. D. M., de Pater, G., van Opstal, J. M., Volders, P. G. A., & Vos, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000145162.64183.c8 · Cited by 361

Drug‐Induced Torsades de Pointes and Implications for Drug Development

Fenichel, R. R., Malík, M., Antzelevitch, C. N., Sanguinetti, M. C., Roden, D. M., Priori, S. G., Ruskin, J. N., Lipicky, R. J., Cantilena, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 343

QTc Interval Screening in Methadone Treatment

Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 340

Long QT syndrome: reduced repolarization reserve and the genetic link

Roden, D. M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 318

Accurate electrocardiographic assessment of the QT interval: Teach the tangent

Postema, P. G., de Jong, J. S. S. G., van der Bilt, I. A. C., & Wilde, A. A. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.037 · Cited by 317

Cellular mechanisms underlying the long QT syndrome

Antzelevitch, C. N., & Shimizu, W. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200201000-00007 · Cited by 313

Assessing predictors of drug-induced torsade de pointes

Belardinelli, L., Antzelevitch, C., & Vos, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.002 · Cited by 303

Unique Topographical Distribution of M Cells Underlies Reentrant Mechanism of Torsade de Pointes in the Long-QT Syndrome

Akar, F. G., Yan, G., Antzelevitch, C. N., & ROSENBAUM, D. S. (2002) · Circulation · doi:10.1161/hc1002.105231 · Cited by 301

Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias

Napolitano, C., Schwartz, P. J., Brown, A. M., Ronchetti, E., Bianchi, L. K., Pinnavaia, A., Aquaro, G. D., & Priori, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300

Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT Syndrome

Ackerman, M. J., Tester, D. J., Jones, G. S., Will, M. L., Burrow, C. R., & Curran, M. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1479 · Cited by 295

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1 , and KCNE2 in drug-induced long QT syndrome patients

Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze‐Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 279

Torsade de Pointes Due to Noncardiac Drugs

Zeltser, D., Justo, D., Halkin, A., Prokhorov, V., Heller, K., & Viskin, S. (2003) · Medicine · doi:10.1097/01.md.0000085057.63483.9b · Cited by 273

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data

Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261

Genetics of acquired long QT syndrome

Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 258

The Morphology of the QT Interval Predicts Torsade de Pointes During Acquired Bradyarrhythmias

Topilski, I., Rogowski, O., Rosso, R., Justo, D., Copperman, Y., Glikson, M., Belhassen, B., Hochenberg, M., & Viskin, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.058 · Cited by 236

Drug-induced long QT and torsade de pointes: recent advances

Kannankeril, P. J., & Roden, D. M. (2006) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 230

Is Gender a Risk Factor for Adverse Drug Reactions?

Drici, M., & ment, N. C. (2001) · Drug Safety · doi:10.2165/00002018-200124080-00002 · Cited by 227

Female Gender as a Risk Factor for Drug-Induced Cardiac Arrhythmias: Evaluation of Clinical and Experimental Evidence

Ebert, S. N., Liu, X., & Woosley, R. L. (1998) · Journal of Women s Health · doi:10.1089/jwh.1998.7.547 · Cited by 223

A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y

Plant, L. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25618 · Cited by 216

Electrophysiological Mechanism of the Characteristic Electrocardiographic Morphology of Torsade de Pointes Tachyarrhythmias in the Long-QT Syndrome

El‐Sherif, N., Chinushi, M., Caref, E. B., & Restivo, M. (1997) · Circulation · doi:10.1161/01.cir.96.12.4392 · Cited by 215

Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations

Carlsson, L. M. S., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213

Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Mason, J. W., Hondeghem, L. M., & Katzung, B. G. (1984) · Circulation Research · doi:10.1161/01.res.55.3.278 · Cited by 211

Cardiac Actions of Erythromycin

Drici, M., Knollmann, B. C., Wang, W.-X., & Woosley, R. L. (1998) · JAMA · doi:10.1001/jama.280.20.1774 · Cited by 197

Normalization of Acquired QT Prolongation in Humans by Intravenous Potassium

Choy, A. M., Lang, C. C., Chomsky, D. M., Rayos, G. H., Wilson, J. R., & Roden, D. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2149 · Cited by 196

Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome

Wu, L., Shryock, J. C., Song, Y., Li, Y., Antzelevitch, C. N., & Belardinelli, L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066100 · Cited by 193

T wave alternans in idiopathic long QT syndrome

Zaręba, W., Moss, A. J., le Cessie, S., & Hall, W. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90653-x · Cited by 185

Effect of Clinical Phenotype on Yield of Long QT Syndrome Genetic Testing

Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.056 · Cited by 184

The long QT syndrome family of cardiac ion channelopathies: A HuGE review

Modell, S. M., & Lehmann, M. H. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000204468.85308.86 · Cited by 176

Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias

Yang, T., Snyders, D. J., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 172

Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype

von Bahr, C., Movin, G., Nordin, C., Lidén, A., Hammarlund‐Udenaes, M., Hedberg, A. L., Ring, H., & Sjöqvist, F. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.22 · Cited by 158

Clinical safety profile of sotalol in patients with arrhythmias

Soyka, L. F., Wirtz, C., & Spangenberg, R. B. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90207-h · Cited by 155

Ibutilide

Murray, K. T. (1998) · Circulation · doi:10.1161/01.cir.97.5.493 · Cited by 155

Concomitant Risk Factors in Reports of Torsades de Pointes Associated with Macrolide Use: Review of the United States Food and Drug Administration Adverse Event Reporting System

Shaffer, D., Singer, S., Korvick, J. A., & Honig, P. K. (2002) · Clinical Infectious Diseases · doi:10.1086/340861 · Cited by 151

Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter

Kowey, P. R., VanderLugt, J. T., & Luderer, J. R. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00566-8 · Cited by 133

Torsade de Pointes Associated with the Use of Intravenous Haloperidol

Wilt, J. L., Minnema, A. M., Johnson, R. F., & Rosenblum, A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00007 · Cited by 126

AHA Scientific Statement

Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C. E., Swiryn, S., & Hare, G. F. V. (2005) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200503000-00003 · Cited by 125

How Really Rare Are Rare Diseases?:

Schwartz, P. J., Priori, S. G., & Napolitano, C. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03339.x · Cited by 124

Electrocardiographic and Clinical Predictors of Torsades de Pointes Induced by Almokalant Infusion in Patients with Chronic Atrial Fibrillation or Flutter: A Prospective Study

Houltz, B., Darpö, B., Edvardsson, N. G., Blomström, P., Brachmann, J., Crijns, H. J. G. M., Jensen, S. M., Svernhage, E., Vallin, H., & Swedberg, K. B. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00150.x · Cited by 117

In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs

Bruin, M. L. D., Langendijk, P. N. J., Koopmans, R. P., Wilde, A. A. M., Leufkens, H. G. M., & Hoes, A. W. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02722.x · Cited by 113

Role of SCN5A Y1102 Polymorphism in Sudden Cardiac Death in Blacks

BURKE, A. P., Creighton, W., Mont, E. K., Li, L., Hogan, S. L., Kutys, R., Fowler, D. R., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.482760 · Cited by 108

Does Low-dose Droperidol Administration Increase the Risk of Drug-induced QT Prolongation and Torsade de Pointes in the General Surgical Population?

Nuttall, G. A., Eckerman, K. M., Jacob, K. A., Pawlaski, E. M., Wigersma, S. K., Marienau, M. E. S., Oliver, W. C., Narr, B. J., & Ackerman, M. J. (2007) · Anesthesiology · doi:10.1097/01.anes.0000281893.39781.64 · Cited by 102

Drug Therapy For Torsade de Pointes

Banai, S., & Tzivoni, D. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01224.x · Cited by 98

Amiodarone and Torsade de Pointes

Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 93

QTc Interval in the Assessment of Cardiac Risk

Elming, H., Brendorp, B., Køber, L., Sahebzadah, N., & Torp-Petersen, C. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016345412555 · Cited by 90

Drug induced QT prolongation.

Zaręba, W. (2007) · PubMed · Cited by 90

Effects of low potassium or magnesium concentrations on isolated cardiac tissue

Roden, D. M., & Iansmith, D. H. S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90128-8 · Cited by 90

Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug–associated torsades de pointes

Lehtonen, A., Fodstad, H., Laitinen-Forsblom, P. J., Toivonen, L. K., KONTULA, K. K., & Swan, H. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.01.019 · Cited by 90

Drug‐induced torsades de pointes: a review of the Swedish pharmacovigilance database

Åström‐Lilja, C., Odeberg, J. M., Ekman, E., & Hägg, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1607 · Cited by 88

Early after-depolarizations and torsade de pointes: Implications for the control of cardiac arrhythmias by prolonging repolarization

Roden, D. M. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_h.56 · Cited by 87

Drug-induced torsades de pointes: The evolving role of pharmacogenetics

Fitzgerald, P., & Ackerman, M. J. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.08.007 · Cited by 85

Thorough QT/QTc Not So Thorough: Removes Torsadogenic Predictors from the T‐Wave, Incriminates Safe Drugs, and Misses Profibrillatory Drugs

Hondeghem, L. M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00347.x · Cited by 82

How to correct the QT interval for the effects of heart rate in clinical studies

Davey, P. P. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00008-x · Cited by 80

QT lengthening and life-threatening arrhythmias associated with fexofenadine

Pinto, Y. M., Gelder, I. C. V., Heeringa, M. J., & Crijns, H. J. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01009-0 · Cited by 78

Risk Factors and Predictors of Torsade de Pointes Ventricular Tachycardia in Patients With Left Ventricular Systolic Dysfunction Receiving Dofetilide

Pedersen, H. S., Elming, H., Seibæk, M., Burchardt, H., Brendorp, B., Torp-Pedersen, C. T., & Køber, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.020 · Cited by 74

Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest

Tarabar, A. F., Hoffman, R. S., & Nelson, L. S. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160963 · Cited by 72

Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors

Justo, D., Prokhorov, V., Heller, K., & Zeltser, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00469.x · Cited by 70

Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome

Norstrand, D. W. V., Tester, D. J., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.012 · Cited by 67

Life‐threatening ventricular tachycardia due to liquorice‐induced hypokalaemia

Eriksson, J. W., Carlberg, B., & Hillörn, V. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00476.x · Cited by 62

Torsades de Pointes Induced by Erythromycin

Gitler, B., Berger, L. S., & Buffa, S. D. (1994) · CHEST Journal · doi:10.1378/chest.105.2.368 · Cited by 61

Practice Standards for ECG Monitoring in Hospital Settings: Executive Summary and Guide for Implementation

Drew, B. J., & Funk, M. (2006) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2006.01.007 · Cited by 59

Individual Patterns of QT/RR Relationship

Batchvarov, V. N., & Malík, M. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016393328485 · Cited by 56

Frequency of high‐risk use of QT‐prolonging medications

LaPointe, N. M. A., Curtis, L. H., Chan, K. A., Kramer, J. M., Lafata, J. E., Gurwitz, J. H., Raebel, M. A., & Platt, R. G. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1155 · Cited by 55

What Is the Minimal Pacing Rate that Prevents Torsades de Pointes? Insights from Patients with Permanent Pacemakers

Pinski, S. L., Eguía, L. E., & Trohman, R. G. (2002) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2002.01612.x · Cited by 54

Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes

Mank-Seymour, A. R., Richmond, J., Wood, L. S., Reynolds, J. M., Fan, Y.-T., Warnes, G. R., Milos, P. M., & Thompson, J. F. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.08.020 · Cited by 54

Persistent Atrial Fibrillation Is Associated With Reduced Risk of Torsades de Pointes in Patients With Drug-Induced Long QT Syndrome

Darbar, D., Kimbrough, J., Jawaid, A., McCray, R., Ritchie, M. D., & Roden, D. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.066 · Cited by 49

Torsade de pointes ventricular tachycardia a complication of disopyramide shared with quinidine

Wald, R. W., Waxman, M. B., & Colman, J. M. (1981) · Journal of Electrocardiology · doi:10.1016/s0022-0736(81)80013-1 · Cited by 48

Relation of QT Interval Measurements to Evolving Automated Algorithms from Different Manufacturers of Electrocardiographs

Kligfield, P., Hancock, E. W., Helfenbein, E. D., Dawson, E. J., Cook, M. A., Lindauer, J. M., Zhou, S., & Xue, J. Q. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.060 · Cited by 48

Clinical Evaluation of Adverse Effects During Bepridil Administration for Atrial Fibrillation and Flutter

Yasuda, M., Nakazato, Y., Sasaki, A., Kawano, Y., Nakazato, K., Tokano, T., & Daida, H. (2006) · Circulation Journal · doi:10.1253/circj.70.662 · Cited by 48

Torsade de pointes induced by N-Acetylprocainamide

Chow, M. J., Piergies, A. A., Bowsher, D. J., Murphy, J. J., Kushner, W., Ruo, T. I., Asada, A., Talano, J. V., & Atkinson, A. J. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80111-4 · Cited by 44

Hypocalcemic torsades de pointes

Akiyama, T., Batchelder, J. E., Worsman, J., Moses, H. W., & Jedlinski, M. (1989) · Journal of Electrocardiology · doi:10.1016/0022-0736(89)90026-5 · Cited by 42

Torsades de pointes induced by antibiotics

Justo, D., & Zeltser, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.12.003 · Cited by 41

Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States

Singh, B. N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90962-x · Cited by 37

Concomitant Use of Antipsychotics and Drugs That May Prolong the QT Interval

Roe, C. M., Odell, K. W., & Henderson, R. R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00013 · Cited by 37

An algorithm for continuous real-time QT interval monitoring

Helfenbein, E. D., Zhou, S., Lindauer, J. M., Field, D. Q., Gregg, R. E., Wang, J. J., Kresge, S. S., & Michaud, F. P. (2006) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2006.05.018 · Cited by 36

Torsades de pointes: Prevention and therapy

Keren, A., & Tzivoni, D. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029778 · Cited by 28

Prophylactic Magnesium to Decrease the Arrhythmogenic Potential of Class III Antiarrhythmic Agents in a Rabbit Model

White, C. M., Xie, J., Chow, M. S. S., & Kluger, J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.635.31528 · Cited by 28

Ciprofloxacin- and Hypocalcemia-Induced Torsade de Pointes Triggered by Hemodialysis

Daya, S. K., Gowda, R. M., & Khan, I. A. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200401000-00014 · Cited by 27

Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration

Nakasone, H., Sugama, R., Sakugawa, H., Matayoshi, R., Miyagi, T., Maeshiro, T., Yamashiro, T., Higa, F., Hokama, A., Kinjo, F., et al. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170061 · Cited by 25

Acquired long QT syndrome: Risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I

Raviña, T., Raviña, P., & Gutiérrez, J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.084 · Cited by 24

Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports

Justo, D., & Zeltser, D. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01278.x · Cited by 23

Preventing Torsades de Pointes by Careful Cardiac Monitoring in Hospital Settings

Sommargren, C. E., & Drew, B. J. (2007) · AACN Advanced Critical Care · doi:10.4037/15597768-2007-3007 · Cited by 22

Management of Ventricular Dysrhythmia Secondary to Trazodone Overdose

Chung, K.-J., Wang, Y.-C. L., Liu, B., & Supernaw, R. B. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.02.036 · Cited by 22

Block of IKs by the Diuretic Agent Indapamide Modulates Cardiac Electrophysiological Effects of the Class III Antiarrhythmic Drug dl-Sotalol

Fiset, C., Drolet, B., Hamelin, B. A., & Turgeon, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36991-5 · Cited by 20

Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia

Dı́az-Castro, Ó., Puchol, A., Almendral, J. M., Torrecilla, E. G., Arenal, Á., & Martínez‐Sellés, M. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2003.10.003 · Cited by 19

Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome

Kawabata, M., Hirao, K., Sasaki, T., Sakurai, K., Inagaki, H., Hachiya, H., & Isobe, M. (2008) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2007.09.009 · Cited by 18

[The value of magnesium in intensive care medicine].

Lüderitz, B., & Manz, M. G. (1994) · PubMed · Cited by 8

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036

Heart disease and stroke statistics-2018 update: a report from the american heart association

Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

Authors Task Force Members, Kristensen, S. D., Knuuti, J., Saraste, A., Anker, S. D., Bøtker, H. E., Hert, S. D., Ford, I., González‐Juanatey, J. R., Görenek, B., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,687

Prevention of Torsade de Pointes in Hospital Settings A Scientific Statement From the American Heart Association and the

Menon, V., Roden, D. M., Zareba, W., Drew, B. J., Ackerman, M. J., Funk, M., & Gibler, W. B. (2010)

2010 AHA/ACCF Scientific Statement for Prevention of Torsade de Pointes in Hospital Settings

Chong-bai, X. (2011) · Advances in Cardiovascular Diseases

Incidence of Torsade de Pointes in a teriary hospital population

Vandael, E., Vandenberk, B., Vandenberghe, J. U., Pincé, H., Willems, R., & Foulon, V. (2016) · Acta Cardiologica

[Torsades de pointes].

Kishi, F., Nomura, M., Saito, K., Ito, S., & Nakaya, Y. (1996) · PubMed

Torsade de pointes.

Santinelli, V., Chiariello, M., & Condorelli, M. (1982) · Circulation · doi:10.1161/01.cir.66.1.250 · Cited by 6